IGF1R and lung cancer: Our finding that Crizo plus Dox synergistically induce HCC and other cancer cell death is consistent with earlier reports indicating that Crizo acts synergistically with topotecan in killing neuroblastoma cells (44), or combination of Crizo and IGF-1R inhibitor is synergistically cytotoxic to lung cancer cells (45).